Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil Response by ChAT and APOE Genotype in Alzheimer's Disease
NCT00381381Phase 4Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2006
- Primary completion
- Aug 2008
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of donepezil in Alzheimer's disease (AD), sponsored by Eisai Co., Ltd. Primary endpoint: Consortium to Establish a Registry for Alzheimer's Disease - Korean version at 26 weeks. Started May 2006; status: completed.
02
Drugs
donepezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00381381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00381381.